Belviq is Now on the Market
This year in the world of weight loss, the new weight loss pill, Belviq, has finally hit the market. Last year, the FDA obliged by approving the first new weight-loss drugs in more than a decade. The first, Qsymia, has been available with a prescription for nearly a year while the second, Belviq, has been availble by prescription for only a few months.
Belviq increases the feeling of fullness and lowers cravings in some patients. It stimulates receptors in the brain.
The pill has been approved for use in adults with a body mass index (BMI) of 30 or greater or for the use in adults with a BMI of 27 or greater who are overweight with a least one weight-related health condition such as type 2 diabetes or high cholesterol.